Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3

Clinical trial NCT00411385 · COMPLETED

Trial details

NCT number: NCT00411385
Sponsor: Human Genome Sciences Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2007-02-01
Primary completion: 2008-10-01
Enrollment: 933

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.